https://www.selleckchem.com/pr....oducts/nsc697923.htm
15). However, the ventricular assist device-free survival rate was significantly higher in patients with central than peripheral support (82.2% vs 52.0%, respectively; P = 0.017). A peak creatine kinase-MB level of 180 IU/l, rhythm disturbance and aortic valve closure were detrimental to functional recovery in patients with central support. Conversion to central ECLS is feasible and safe in patients with fulminant myocarditis. Patients with severe myocardial injury as shown by a high creatine kinase-MB level, rhythm disturbance an
Like
Comment
Share
